Trials / Conditions / Lupus Nephritis - WHO Class III
Lupus Nephritis - WHO Class III
3 registered clinical trials studyying Lupus Nephritis - WHO Class III — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Safety and Efficacy of ONT01 in Lupus NCT07107659 | Hospital for Special Surgery, New York | EARLY_Phase 1 |
| Active Not Recruiting | AB-101 in Combination With B-Cell Depleting mAb in Patients Who Failed Treatment for Class III or IV Lupus Nep NCT06265220 | Artiva Biotherapeutics, Inc. | Phase 1 |
| Active Not Recruiting | KYSA-3: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Refractor NCT06342960 | Kyverna Therapeutics | Phase 1 / Phase 2 |